5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial. (linkinghub.elsevier.com)

Authors: Rivera S … Michiels S Journal: The Lancet Published: 2026-03-07 DOI: https://doi.org/10.1016/S0140-6736(25)02597-8